“…In the human placenta, DNA methylation (DNAme) has a unique profile that shifts throughout gestation in association with changes in cell composition, gene expression, and in response to pregnancy complications, among other factors (Robinson and Price, 2015;Yuan et al, 2021). Many studies have reported PE-associated alterations in placental DNAme (Blair et al, 2013;Chu et al, 2014;Martin et al, 2015;Yeung et al, 2016;Kim, 2017;Wilson et al, 2018;Wang et al, 2019a;Lim et al, 2020;Workalemahu Tsegaselassie et al, 2020), but findings are not consistently reproduced across studies (Cirkovic et al, 2020). Discrepancies between studies in definitions of PE used, study design (e.g., analysing all PE compared to analysing specific subtypes such as EOPE, LOPE), the use of different metrics to assess reproducibility (e.g., a CpG found to be significantly differentially methylated in one cohort may not replicate in an independent cohort, but a proximal and correlated CpG might), and platforms used to measure DNAme, among others, can contribute to poor reproducibility across studies.…”